Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House Education Committee approves pharmacy, medical formulary updates; adds Stelara biosimilars
2898363 · April 8, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
Summary
The House Education Committee reviewed and approved updates to the pharmacy and medical formularies, including the addition of several biosimilars for the biologic drug Stelara, officials said.
Grant Wallace, director of the Employee Benefits Division, told the House Education Committee that the first two agenda items were routine formulary reviews and recommended moving lower-cost biosimilars for Stelara onto the state pharmacy and medical drug formularies.
Wallace said the pharmacy formulary update (exhibit C‑1) lists Yaxentik and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans
